Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856264) titled 'PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis' on Sept. 28.

Study Type: Observational

Primary Sponsor: Fundación Santa Fe de Bogota

Condition: Hyperlipidemia Atherosclerotic Cardiovascular Disease (ASCVD)

Recruitment Status: Not recruiting

Date of First Enrollment: February 1, 2027

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07856264

Published by HT Digital Content Services with permission from Health Daily Digest....